KDR and pancreatic ductal adenocarcinoma: However, loss of stromal Hh pathway activation in KP pancreas ductal adenocarcinoma (PDAC) increased tumor blood vessel density and inhibition of angiogenesis through VEGFR2 antagonism in KP;Shhfl/fl PDACs prolonged mouse survival [20].